.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 008867

« Back to Dashboard
NDA 008867 describes RAUWILOID, which is a drug marketed by 3M and is included in one NDA. Additional details are available on the RAUWILOID profile page.

The generic ingredient in RAUWILOID is alseroxylon. Additional details are available on the alseroxylon profile page.

Summary for NDA: 008867

Tradename:
RAUWILOID
Applicant:
3m
Ingredient:
alseroxylon
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength2MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc